JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200877200 on February 22, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16396-16402, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16396    most recent
M200877200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhunia, A. K.
Right arrow Articles by Chatterjee, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhunia, A. K.
Right arrow Articles by Chatterjee, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

GD3 Recruits Reactive Oxygen Species to Induce Cell Proliferation and Apoptosis in Human Aortic Smooth Muscle Cells*

Anil Kumar BhuniaDagger , Günter Schwarzmann§, and Subroto ChatterjeeDagger

From the Dagger  Department of Pediatrics, Lipid Research Atherosclerosis Unit, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21044 and the § Kekulé-Institut für Organische Chemie und Biochemie der Universität Bonn, D-53121 Bonn, Germany

Received for publication, January 28, 2002, and in revised form, February 21, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Sialic acid containing glycosphingolipids (gangliosides) are expressed on the surface of all mammalian cells and have been implicated in regulating various biological phenomena; however, the detailed signaling mechanisms involved in this process are not known. We report here a novel aspect of disialoganglioside, GD3-mediated regulation of cell proliferation and cell death via the recruitment of reactive oxygen species (ROS). A low concentration (2.5-10 µM) of GD3, incubated with human aortic smooth muscle cells for a short period of time (10-30 min), stimulates superoxide generation via the activation of both NADPH oxidase and NADH oxidase activity. This leads to downstream signaling leading to cell poliferation and apoptosis. However, [3H]GD3 incubated with the cells under such conditions was found in a trypsin-sensitive fraction that was separable from endogenous GD3. The exact mechanism causing ROS generation and downstream signaling remains to be elucidated. The uptake of GD3 was accompanied by a 2.5-fold stimulation in the activity of mitogen-activated protein (MAP) kinase and 5-fold stimulation in cell proliferation. Preincubation of cells with membrane-permeable antioxidants, pyrrolidine dithiocarbamate, and N-acetylcysteine abrogated the superoxide generation and cell proliferation. In contrast, at higher concentrations (50-200 µM) GD3 inhibited the generation of superoxides but markedly stimulated the generation of nitric oxide (NO) (10-fold compared with control). This in turn stimulated mitochondrial cytochrome c release and intrachromosomal DNA fragmentation, which lead to apoptosis. In sum, at a low concentration, GD3 recruits superoxides to activate p44 MAPK and stimulates cell proliferation. In contrast, at high concentrations GD3 recruits nitric oxide to scavenge superoxide radicals that triggered signaling events that led to apoptosis. These observations might have relevance in regard to the potential role of GD3 in aortic smooth muscle cell proliferation and apoptosis that may contribute to plaque rupture in atherosclerosis.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Glycosphingolipids (GSL)1 are ubiquitously expressed components of mammalian plasma membranes and have been implicated in the control of cell growth regulation through modulation of transmembrane signaling (1-3). Gangliosides are a species of GSL that contain sialic acids. GD3 is a disialogaglioside implicated in cell growth and proliferation. GD3 is overexpressed in some tumors, such as human melanoma in which it serves as a tumor antigen (4-8). Increased levels of GD3 have also been associated with proliferative diseases like atherosclerosis (9, 10). Recently, it was reported that the endogenous expression of GD3 synthase leads to proliferation of PC12 cells through the Ras-MAPK pathway (11). On the other hand, the overexpression of GD3 synthase leads to an increased level of GD3 that in turn contributes to apoptosis in human leukemic cells (12). In addition, studies suggest that GD3 mediates TNF-alpha - and Fas/Apo-1/CD-95-induced apoptosis in such cells. Collectively, these studies imply that GD3 might have a dual role in modulating cell proliferation and apoptosis. However, the signaling mechanisms involved in this phenomenon have not been evaluated. We rationalized that because cultured human aortic smooth muscle cells and normal human aorta contain a significant amount of GD3, it may well be implicated in proliferation. On the other hand a marked increase in the level of GD3 in human plaque from patients with atheroscleosis may contribute to plaque instability via inducing apoptosis.

Reactive oxygen species (ROS) are usually generated in response to diverse external stimuli, such as TNF-alpha , TGF-beta , PDGF, EGF (13), and lipid second messengers, e.g. lysophosphadic acid (14) and lactosylceramide (15). At low concentrations ROS may play the role of an intracellular messenger of various molecular events (16), including cell proliferation and apoptosis. However, the generation of large amounts of ROS is considered cytotoxic and contributes to apoptosis. ROS represents multiple molecular species, including singlet oxygen, superoxides (O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>), H2O2, NO, peroxynitrite (ONOO-), the thiperoxyradical (RSOO·), and the hydroxyl radical (HO·). Superoxides are the early molecular species of ROS that are generated as a consequence of the interaction of cells with external stimuli that in turn generate H202, HO·, etc. The generation of ROS has been related to the activation of transcriptional factors, for example, AP-1, NFkappa B, and mitogen-activated protein kinase (p44 MAPK) implicated in cell proliferation. On the other hand, NO as well as the generation of high levels of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> activate caspases that in turn lead to the dissolution of the cell membrane and nuclear components resulting in apoptosis. Collectively, these studies and our own (15-17) led us to hypothesize that GD3 may well recruit ROS to induce cell proliferation and apoptosis.

In this paper, we report that exogenously supplied [3H]GD3 associates with the cell membrane mainly in a trypsin-sensitive state. Subsequently, it recruits ROS's such as O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> and NO as biological sensors that serve a dual role in cell proliferation and apoptosis, respectively, in aortic smooth muscle cells (A-SMC). Because GD3 is a major GSL in normal A-SMC, and its level is markedly increased in human aortic plaque intima (8), our findings may be relevant to the pathological sequalae including the progression of atherosclerosis via A-SMC proliferation and the apoptosis of A-SMC that may contribute to plaque rupture.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Isotopes and Chemicals-- [3H]Thymidine and [gamma -32P]ATP (222 TBq/mmol) were purchased from Amersham Biosciences. Bovine milk GD3 was purchased from Matreya (Pleasant Gap, PA) and labeled with 3H, employing palladium-catalyzed reduction of the sphingosine double bond (18). [3H]GD3 was purified further by chromatography in silica gel Lichro prep Si60 (E. Merck, AG Darmstadt, Germany) with choloroform/methanol/water (60:40:9, v/v). The specific activity of the [3H]GD3 was 147.9 MBq/µmol. A stock solution of GD3 was prepared in dimethyl sulfoxide and suitable aliquots added to the culture dishes. Anti-MAPK antibody (specific for p44 MAPK and p42 MAPK), and MAPK-specific substrate peptides (APRTPGGRR), were obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Anti-cytochrome c antibody was obtained from PharMingen (San Diego, CA). The DNA isolation kit was purchased form Qiagen Inc. GSL and all other chemicals were purchased from Sigma.

Cells-- Human aortic smooth muscle cells were prepared and cultured in minimal essential medium supplemented with 10% fetal calf serum, penicillin (100 µg/ml), streptomycin (100 µg/ml), and glutamine (50 µg/ml) according to the procedure of Ross (19).

Vehicle for Gangliosides-- Stock solutions of gangliosides were prepared in dimethyl sulfoxide (Me2SO) and added to cultured cells to achieve the final desired concentrations of gangliosides. The maximum concentration of Me2SO exposed to cells was <0.01%, and cells that were incubated with 0.01% Me2SO served as a control.

Incorporation of [3H] GD3 into Human Aortic Smooth Muscle Cells-- The incorporation of [3H]GD3 into human aortic smooth muscle cells was carried out exactly as described by Sonderfeld et al. (20). Briefly, confluent monolayer of aortic smooth muscle cells were incubated in minimum essential medium containing 0.3% heat-inactivated fetal bovine serum and 200 nmol of [3H]GD3. At 1-, 2.5-, 5-, 10-, 20-, and 30-min time intervals medium was removed, and the monolayers were washed three times with ice-cold phosphate-buffered saline. Total radioactivity in the washed cell pellets was measured by scintillation spectrometry using Aquasol-II as the scintillation fluid (PerkinElmer Life Sciences). Next the cells were harvested following trypsinization (0.25% trypsin for 15 min at 37 °C and centrifuged (1,000 × g for 5 min, 4 °C). The cell pellets were washed three times with phosphate-buffered saline, centrifuged, and radioactivity associated with the cells was measured by scintillation spectrometry.

Measurement of Superoxide Production in Intact Cells-- Lucigenin, an acridylium compound (Sigma) that emits light on reduction and interaction with O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>, was used to measure the level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> production (15). Cultured A-SMC was harvested, and the superoxide was measured in intact cell suspensions as described previously using dark-adapted lucigenin (500 µM) in a balanced salt solution (15). The viability of the suspended cells as determined by the trypan blue exclusion principle was >90%. The ganglioside solutions (dissolved in Me2SO) were added to the cells to achieve a final concentration of Me2SO that was equal to 0.01%. Moreover, the vehicle (0.01% Me2SO) served as a control in most experiments.

Cell Fractionation and NADH/NADPH Oxidase Assay-- Confluent human A-SMC was incubated with 5 µM GD3. At different time intervals cells were harvested and homogenized in a lysis buffer containing 20 mM potassium phosphate buffer, pH 7.0, 1 mM EGTA, 10 µg/ml aprotinin, 0.5 µg/ml leupeptin, 0.7 µg/ml pepstatin, and 0.5 mM phenylmethylsulfonyl fluoride. The membrane (both plasma membrane and mitochondrial) and cytosol were prepared by the centrifugation of the cell homogenate at 29,100 × g for 20 min at 4 °C (15). The membrane was resuspended in an original volume of lysis buffer. NADH and NADPH oxidase activity was measured in both cytosolic and membrane fraction as described previously by the lucigenin chemiluminescence method (15) using 250 µM lucigenin as the electron acceptor and either 100 µM NADPH or 100 µM NADH as an electron donor. In some experiments, NADPH oxidase activity was measured in the membrane preparations in the presence of 1 mM rotenone (mitochondrial poison). The protein content was measured by the Lowry et al. (21) method with bovine serum albumin serving as the standard.

Immunoprecipitation and MAP Kinase Activity Assay-- A-SMC was lyzed in 100 µl of radioimmune precipitation buffer containing 150 mM NaCl, 5 mM EGTA, 5 mM EDTA, 10 mM sodium fluoride, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 µg/ml pepstatin, 25 mM Tris/HCl, pH 7.4, 1% Triton X-100, and Nonidet P-40. The lysate was centrifuged and immunoprecipitated with the anti-MAP kinase antibody conjugated with agarose as described earlier (22). Immunocomplex was directly used for MAP kinase activity assay (22). Briefly, 25 µl of total reaction mixture contained 1 mg/ml myelin basic protein peptide (APRTPGGRR), 50 µM [gamma -32P]ATP (1,800 cpm/pmol), 0.5 mM adenosine 3',5'-cyclic monophosphate-dependent protein kinase inhibitor, and assay dilution buffer containing 30 mM beta -glycerophosphate, 20 mM MOPS, pH 7.2, 20 mM MgCl2, 5 mM EGTA, 1 mM dithiothreitol, 0.5 mM Na3VO4, and 2-3 µg of immunoprecipitated protein. The reaction was initiated upon the addition of [gamma -32P] ATP for 15 min at 30 °C and terminated with the addition of 10 µl of ice-cold 40% trichloroacetic acid. One part of the reaction mixture was spotted onto p81 phosphocellulose paper. Free [gamma -32P]ATP was removed by five washes (5 min each) with 1% phosphoric acid and counted in a scintillation counter. The remaining part of the reaction mixture was run into 15% SDS-PAGE, and the gel was dried and autoradiographed.

Internucleosomal DNA Fragmentation Assay-- Cells were treated with various agonists and antagonists for 12 h, and the DNA was isolated and analyzed by DNA electrophoresis as described earlier (23).

Cytochrome c Release Assay-- Following incubation with agonists, cells were washed, harvested in ice-cold phosphate-buffered saline, and suspended in 100 µl of extraction buffer containing 20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 5 mM EDTA, 5 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, and 0.25 mM sucrose (24). Cytosol was prepared, and the level of cytosolic cytochrome c was determined by Western blotting using a monoclonal anti-cytochrome c antibody.

Measurement of Nitric Oxide Production-- Nitrite production, a stable product of NO, was measured by the Griess reagent as described previously (25). The cells were incubated with the agonist and antagonists. At the end of incubation, 500 µl of culture medium was mixed with an equal volume of Griess reagent (1 part of 1% sulfanilamide in 2.5% phosphoric acid and 1 part of 0.1% naphthylethylenediamine dihydrochloride). The colorimetric absorbance at 550 nm was measured, and the nitrite concentration was determined using a standard curve generated using sodium nitrite.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Time Kinetics of [3H]GD3 Incorporation into Human Aortic Smooth Muscle Cells-- As shown in Fig. 1 (top panel), total incorporation of [3H]GD3 into human aortic smooth muscle cells occurred very rapidly during the 30-min duration of this study. However, very little radioactivity remained associated with the cells following trypsinization of cells (Fig. 1, bottom panel).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Uptake kinetics of [3H]GD3 into human aortic smooth muscle cells. The cells were incubated at 37 °C with 50 µM GD3. At the indicated time periods, total cell-associated radioactivity (top panel) and trypsin-resistant radioactivity was measured by scintillation spectrometry.

Effects of Gangliosides on Superoxide Generation-- GD3 (10 µM) stimulated the level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation about 5-fold as compared with the control (Fig. 2). Other gangliosides like, GM1, GM2, and globotriosylceramide did not alter the O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> level in these cells. LacCer also stimulated O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation about 7-fold higher than the control and served as a positive control. On the other hand, GM3 decreased O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of various gangliosides on generation of superoxide in H-ASMC. When 80-90% confluent, H-ASMC were harvested and suspended in balanced salt solution. Intact cell suspensions were placed in a 96-well black microtiter plate (Packard) for the measurement of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation by the lucigenin chemiluminescence method. In a final volume of 200 µl the assay mixture contained a 10 µM concentration of the indicated gangliosides and 250 µM lucigenin, and after 10 min the rate of generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> was measured. Data presented here are the average + S.D. of five individual experiments. , vehicle; black-square, treatments.

Effects of Time and Concentration of GD3 on Superoxide Production and GSH Levels-- GD3 stimulated the generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> in H-ASMC in a concentration- and time-dependent manner (Fig. 3, A and B). The maximum stimulation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> (~5-fold) was observed using (10 µM) GD3 (Fig. 2A), but at a relatively higher concentration of GD3 (50-200 µM) the level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> was below the base-line value (Fig. 3A). Time kinetics studies reveal a lag time of about 2.5 min in O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> production in cells stimulated by GD3. Subsequently, O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> production increased linearly with time and attained a peak level at about 10 min of incubation with GD3 (10 µM). Thereafter, O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> production moderately decreased in these cells. The preincubation of cells with antioxidant PDTC completely abrogated GD3 induced O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation (Fig. 3C). However, superoxide dismutase partially inhibited GD3 induced O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> levels (data not shown). These findings suggest that GD3-induced O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> levels were both endogenous and exogenous. Interestingly, as the concentration of GD3 in the incubation mixture increased, it was accompanied by a marked decrease in the level of GSH in these cells (Fig. 3D). A 50% decrease in the GSH level occurred in cells incubated with 25 µM GD3, and this level was sustained up to 200 µM (Fig. 3D).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of time and concentrations of GD3 on the production of superoxide in H-ASMC. Intact cell suspension was prepared as described in legend to Fig. 1. A, generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> in intact cells was measured at different concentrations of GD3, Vehicle (open circle ), GD3 (). B, rate of generation of Oblack-square in intact cells at different time intervals, as indicated: open circle , vehicle; , GD3 (10 µM). C, rate of generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> in intact cells preincubated with GD3 (10 µM) for 10 min, 100 µM PDTC for 1 h, and 100 µM PDTC for 1 h + GD3 (10 µM) for 10 min, 15 mM NAC for 30 min and 15 mM NAC for 30 min + 10 µM GD3 for 10 min. D, the level of GSH content of A-SMC after incubation with vehicle (black-triangle) and different concentrations of GD3 (black-square).

Effect of GD3 on NADPH/NADH Oxidase Activity-- Cell membranes were prepared at varying time intervals after being incubated in A-SMC with/without GD3 (10 µM) and NADPH/NADH oxidase activity was measured. Following a lag time of about 2.5 min, NADPH/NADH oxidase activity increased linearly up to 10 min in cells incubated with GD3 (Fig. 4, A and B). The maximum increase in NADPH oxidase activity (4-fold compared with control) was observed after 10-15-min incubation of cells with GD3 (Fig. 4A) and reached a plateau. Thereafter, there was no NADPH oxidase activity observed in the cytosolic fraction in cells incubated with and without GD3 (data not shown). GD3 maximally increased (1.8-fold) the activity of NADH oxidase in H-ASMC as compared with the control (Fig. 4B) following incubation for 10 min. These time kinetics data were obtained using 10 µM GD3. However, at a relatively higher concentration (100 µM), GD3 decreased the activity of NADPH oxidase to approximately one-half-the control value (data not shown). And this may in part explain a decrease in O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> production in A-SMC incubated with 100 µM GD3 (Fig. 3A).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of GD3 on NADPH/NADH oxidase activity in H-ASMC. Cells were incubated with/without 10 µM GD3 at different time intervals, as indicated, and plasma membrane and cytosol were prepared, as described under "Materials and Methods." NADPH/NADH oxidase activity was measured in both membrane and cytosolic fraction by the rate of generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> using the lucigenin chemiluminescence method. Cells incubated with medium only served as a control. A, NADPH oxidase activity in plasma membrane fraction of both nonstimulated (vehicle only) (open circle ), GD3- (10 µM) stimulated () cells, DPI (triangle ), and DPI + GD3 (10 µM) (black-triangle). B, NADH oxidase activity in membrane fraction of both nonstimulated (vehicle only) (open circle ) and GD3- (10 µM) stimulated () cells. NADPH/NADH oxidase activity in the cytosolic fraction of incubated cells remained unchanged (data not shown).

Effect of GD3 on MAP Kinase Activity and Cell Proliferation-- Fig. 5A represents the phosphorylation of the myelin basic protein peptide (APRTPGGRR) by immunoprecipitated cell lysate following stimulation with various concentrations of GD3. A concentration-dependent increase in MAPK activity was observed up to a concentration of about 10 µM GD3. However, we observed a progressive decline in the level of phosphorylated MBP in cells incubated with 50-200 µM of GD3 (Fig. 5B). In fact, at a concentration of 100 µM GD3, MBP phosphorylation fell below the control value. As shown in Fig. 5B, GD3 (10 µM) exerted a time-dependent stimulation in the activity of MAPK. Interestingly, preincubation of cells with cell-permeable antioxidant N-acetylcysteine and PDTC abrogated GD3 (10 µM) induced MAPK activity (Fig. 5C). GD3 (10 µM) exerted about a 5-fold increase in the incorporation of [3H]thymidine in A-SMC, an index of cell proliferation (Fig. 5D). Preincubated cells with PDTC and NAC completely abrogated GD3 induced increase in [3H]thymidine incorporation.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of GD3 on MAP kinase activity and cell proliferation. Following stimulation of cells with GD3, cell lysate was prepared and immunoprecipitated as described under "Materials and Methods." Activity assay of MAPK was done by MBP (sequence APRTPGGRR) phosphorylation. A, MBP phosphorylation by various concentrations of GD3. B, MAPK activity at different time intervals measured by direct counting vehicle (open circle ) (10 µM) and GD3 (10 µM) stimulated () cells. C, assay of MAPK activity following incubation with NAC (15 mM) for 30 min, PDTC (100 µM) for 1 h, followed by incubation with 10 µM GD3. D, cells were incubated with 10 µM GD3 for 18 h. Next, [3H]thymidine incorporation was measured as described under "Materials and Methods." In some experiments cells were preincubated with 100 µM PDTC for 1 h or 15 mM NAC for 30 min before incubation with 10 µM GD3 for 18 h. Each point is the mean + S.D. of three separate experiments.

Effect of GD3 Concentration on Nitric Oxide in A-SMC-- Following the incubation of A-SMC with 10 µM GD3 for 12 h, there was no production of NO (Fig. 6A). However, at higher concentrations (50-200 µM) GD3 markedly stimulated NO production. A maximum of 5-fold stimulation in NO production was observed with 100-200 µM GD3 (relative to control); this was within the range of stimulation of NO by LPS (10 µg/ml) and interferon-gamma (200 units/ml) for 24 h. GD3-induced NO production was completely inhibited by preincubation of cells with 200 µM NG-monomethyl-L-arginine (NMLA) (Fig. 6B). The incubation of A-SMC with GD3 (0-10 µM) had no effects on apoptosis/DNA ladder formation (Fig. 6C). However, at higher concentration (100-200 µM) GD3 markedly stimulated the intranucleosomal DNA degradation after 24 h, which was abrogated by preincubation of cells with NMLA (200 µM) (Fig. 6C).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of GD3 on nitric oxide production and apoptosis. Following incubation with different concentrations of GD3 as indicated for 24 h, nitrite production was measured by griess reagent (A). , vehicle; , GD3. B, NMLA inhibited GD3-induced NO production. C, DNA ladder formation by different concentrations of GD3, as indicated.

Effect of GD3 on the Release of Cytochrome c-- At a concentration of 10 µM, GD3 did not induce the release of cytochrome c from the motochondria to cytosol. However, as we increased the concentration (50-200 µM) of GD3, a progressive increase in the level of cytochrome c release in cytosol was observed (Fig. 7). As a control we used C2-ceramide (1 µM), which also stimulated the release of mitochondrial cytochrome c in these cells.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of GD3 on cytosolic cytochrome c concentration. Cytosolic cytochrome c concentration was measured as described under "Materials and Methods" using different concentrations of GD3.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Although glycosphingolipids have been shown to be present in mammalian cells their functional role in cell proliferation, adhesion and programmed cell death (apoptosis) are only beginning to emerge (1, 2, 26, 27). GD3 is a disialoganglioside that is enriched in human aortic smooth muscle cells. However, in pathological conditions such as in human melanomas and in atherosclerotic plaques, the level of GD3 is markedly elevated (9, 27). In the present study we explain signaling mechanisms by which GD3 can induce aortic smooth muscle cell proliferation as well as apoptosis.

Previous studies employing subcellular fractionation, cell surface labeling, and electron microscope techniques have shown that gangliosides are predominately associated with the plasma membrane (27). The employment of freeze-fracture techniques revealed that globotriosylceramide is localized as microaggregates on the surface of erythrocytes (28). Employing [3H]GD3 in this study we have shown that during early time periods (10-30 min) of incubation, this ganglioside was associated mainly with a trypsin-sensitive cell surface component. Our studies confirm a previous report in human skin fibroblasts in which [3H]GM1 radioactivity was also found to associate with human skin fibroblast in a trypsin-sensitive state. However, upon long term (24 h or more) incubation [3H]GM1 radioactivity was found to reside in trypsin-resistant state in cell membranes. The validity of the trypsinization procedure employed was established by electron spin resonance studies (29). We have not identified the chemical nature of GD3 binding cell surface component, but speculate it to be a glycopeptide/glucan. This speculation is based on a previous observation that a novel carbohydrate-glycosphingolipid interaction occurs between a beta -(1-3) glucan immunomodulator, PGG-glucan, and lactosylceramide in human leukocytes (30).

The relevance of the uptake of [3H]GD3 kinetics with free radicals and cell signaling became evident when we observed that within 5 to 10 min of incubation with GD3 a 2-and 3-fold increase in the generation of superoxide occurred (Fig. 3). These findings suggest that the association of exogenously supplied GD3 to A-SMC cell surface was critical for the production of superoxide. This was accompanied by the activation/phosphorylation of MAPK and other downstream events that collectively contributed to A-SMC proliferation. This phenotypic change could be abrogated by preincubation of cells with NADPH oxidase inhibitor; diphenylene iododium, scavenger of free radicals; N-acetylcysteine; and a membrane permeable antioxidant such as PDTC (15). It may also be possible that GD3 molecules inserted into the plasma membrane (and which may well be in the range of about 1 mol%) are responsible for the formation of ROS, in particular in view of its likely distribution in so called rafts, where its concentration would be even higher. On the other hand, a cross-linking of surface proteins by surface-adhering GD3 micelles may evoke these effects by mimicking transmemmbrane signaling.

Why the exogenous supply of GD3 is required to bring about the generation of superoxide and cell proliferation when A-SMC have significant levels of endogenous GD3 is not clear to us at the present time. However, we have conducted preliminary studies employing wild type Chinese hamster ovary cells and mutant cells (SPB-1) that are devoid of LacCer and GD3 to address this issue. We observed that the basal level of superoxide generated (without exogenous supply of LacCer/GD3) in wild type and mutant cells was very low. However, upon the addition of exogenous LacCer/GD3 (10 µM) the mutant cells and wild type cells produced a 2-5-fold higher level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> as compared with control. Thus our preliminary studies revealed that exogenously supplied LacCer/GD3 stimulates O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation and may contribute to phenotypic changes in mammalian cells. A detailed description of our studies on wild type and mutant Chinese hamster ovary cells will be published elsewhere.2

Lipid second messenger such as LacCer and GD3 have been shown to be produced in cells upon the activation of glycosphingolipid glycosyltransferases by cytokines. For example, we showed that incubation of human umbilical vein endothelial cells with TNF-alpha activated LacCer synthase and generated LacCer. In turn, LacCer activated NADPH oxidase to generate superoxide that was critical in the expression of intercellular cell adhesion molecule (ICAM-1) and the adhesion of neutrophils to human umbilical vein endothelial cells (31). This phenotypic change in cells treated with TNF-alpha was abrogated by preincubation with D-threo-L-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), but was bypassed by LacCer presumably via the generation of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> by the latter compound. Our studies with D-PDMP and phenyl 2-hexadecanoylamino-3-morpholinopropanol (P-PMP) in human umbilical vein endothelial cells and A-SMC have shown that these compounds do not abrogate O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation in these cells. However, only D-PDMP abrogated TNF-alpha -induced O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation and cell adhesion. P-PMP is a specific inhibitor of a glucosyltransferase, an enzyme recruited by mammalian cells to synthesize glucosylceramide, a precursor of LacCer. On the other hand, D-PDMP, in addition to inhibiting this glucosyltransferase activity, also inhibits the activity of LacCer synthase and other GSL glycosyltransferases. In a relevant study with rat hepatocytes TNF-alpha was shown to increase the synthesis of GD3 ~2-fold within 2 h of incubation and rendered the cells apoptotic (32). Moreover, apoptosis was abrogated in rat hepatocytes by the use of P-PMP. Mechanistic studies pursued further employing rat hepatocyte mitochondria revealed that GD3 stimulated the generation of hydrogen peroxide within 15-30 min and enhanced the permeability of mitochondrial membrane to release cytochrome c (33). We also found that incubation of A-SMC with large concentrations of GD3 stimulated the release of cytochrome c that in turn may have contributed to apoptosis (see below).

Previously, the release of cytochrome c from mitochondria to cytosol has been implicated in the apoptotic process. Interestingly, a cell-permeable ceramide (C2-ceramide) also stimulated the release of cytochrome c in our studies but did not generate ROS or NO. This is most likely explained by the observation that ceramide may be converted to GD3, which in turn produces NO to induce apoptosis (11). Collectively, these lines of evidence provide strong support for the hypothesis that GD3 recruits NO to induce apoptosis in cultured H-ASMC.

Reduced GSH is a tripeptide antioxidant, which is present in all mammalian cells at a concentration between 1 and 10 mM (34). The predominant role of GSH is to provide a reduced environment inside the cell and to protect cells from redox stress. Our studies indicate that at higher concentration, GD3 exerts a concentration-dependent decrease in the level of GSH. This may also contribute to the process of apoptosis.

Because apoptosis can be induced in a number of cell systems by hydrogen peroxide, we measured the effects of GD3 on hydrogen peroxide levels. We found that although at low concentrations (10 µM), GD3 stimulated hydrogen peroxide levels, at high concentrations (100-200 µM) it reduced the cellular level of hydrogen peroxides (data not shown). Thus, these studies suggested that GD3 might not employ hydrogen peroxide or superoxide to induce death. On the other hand, previous studies have shown that exposure of cells to a variety of agonists such as pyrogallol, a generator of ROS, increases the DNA binding activity of NFkB that is followed by an increase in an inducible nitric-oxide synthase mRNA (35). Elevated levels of nitric oxide, in turn, stimulated apoptosis. This tenet was substantiated further by determining the effects of GD3 on the levels of nitric oxide by directly measuring the levels of nitrate as well as inducible nitric-oxide synthase levels by Western immunoblot assays. Although GD3 did not induce inducible nitric-oxide synthase in A-SMC and nitrite production at low concentrations, at high concentrations, GD3 stimulated nitric oxide production. Previous studies have indicated that nitric oxide serves as a scavenger of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> and forms toxic peroxynitrite (ONOO-) radicals with endogeneous O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>, which induces apoptosis. Accordingly, we can speculate that at high concentrations, GD3 generates NO that reacts with the endogenous O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>. That markedly decreases the cellular level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> to produce toxic ONOO-. In turn, ONOO- induces apoptosis. This mechanism may also explain why the level of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> decreases as a function of GD3 concentration (Fig. 3A) in addition to a decrease in NADPH oxidase activity.

In summary, nonstimulated SMCs produce very low levels of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> for the maintenance of normal growth and function but do not produce any NO. However, during the progressive phase in atherosclerosis, GD3 may stimulate cell proliferation via induction of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> generation. In advanced atherosclerosis, when large amounts of GD3 have been found to be associated with plaque intima, it may lead to the generation of nitric oxide and subsequently peroxynitrite. Clearly, additional studies in vivo need to be pursued to assess the physiological relevance of GD3-mediated phenotypic changes in vitro in human aortic smooth muscle cells.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Pediatrics, Lipid Research Atherosclerosis Unit, Sphingoglycolipid Signaling and Vascular Biology Laboratory, 550 N. Broadway, Suite 312, Baltimore, MD 21205. Tel.: 410-614-2518; Fax: 410-614-2826; E-mail: chatter@jhmi.edu.

Published, JBC Papers in Press, February 22, 2002, DOI 10.1074/jbc.M200877200

2 A. Bhunia, G. Sato, and S. Chatterjee, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: GSL, glycosphingolipid; MAP, mitogen-activated protein; MAPK, MAP kinase; PDTC, pyrrolidine dithiocarbamate; NAC, N-acetylcysteine; NO, nitric oxide; ROS, reactive oxygen species; A-SMC, aortic smooth muscle cell; NMLA, NG-monomethyl-L-arginine; GSH, reduced glutathione; TNF, tumor necrosis factor; MOPS, 4-morpholinepropanesulfonic acid; PDTC, pyrrolidine dithiocarbamate; D-PDMP, D-threo-L-phenyl-2-decanoylamino-3-morpholino-1-propanol.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Hakomori, S. I., and Igarashi, Y. (1993) Adv. Lipid Res. 25, 147-162[Medline] [Order article via Infotrieve]
2. Chatterjee, S. (1998) Arterioscler. Thromb. Vasc. Biol. 18, 1523-1533[Abstract/Free Full Text]
3. Pukel, C. S., Lloyd, K. O., Travassos, L. R., Dippold, W. G., Oettgen, H. F., and Old, L. J. (1982) J. Exp. Med. 155, 1133-1147[Abstract/Free Full Text]
4. Furukawa, K., and Lloyd, K. O. (1990) in Human Melanoma: Immunology, Diagnostics and Therapy (Ferrone, S., ed) , pp. 15-30, Springer-Verlag, Heidelberg, Germany
5. Nakakuma, H., Sanai, Y., Shiroki, K., and Nagai, Y. (1984) J. Biochem. (Tokyo) 96, 1471-1480[Abstract/Free Full Text]
6. Albino, A. P., Sozzi, G., Nanus, D. M., Jhanwar, S. C., and Houghton, A. N. (1992) Oncogene 7, 2315-2321[Medline] [Order article via Infotrieve]
7. Cheresh, D. A., Pytela, R., Pierschbacher, M. D., Klier, F. G., Ruoslaht, E., and Reisfeld, R. A. (1987) J. Cell Biol. 105, 1163-1173[Abstract/Free Full Text]
8. Nakano, J., Mohan-Raj, B. K., Asagami, C., and Lloyd, K. O. (1996) J. Invest. Dermatol. 107, 543-548[CrossRef][Medline] [Order article via Infotrieve]
9. Mukhin, D., Chao, F. F., and Kruth, H. S. (1995) Arterioscler. Thromb. Vasc. Biol. 15, 1607-1615[Abstract/Free Full Text]
10. Chatterjee, S., Dey, S., Shi, W. Y., Thomas, K., and Hutchins, G. M. (1996) Glycobiology 7, 57-65[Abstract/Free Full Text]
11. Fukumoto, S., Mutoh, T., Hasegawa, T., Miyazaki, H., Okada, M., Goto, G., Furukawa, K., Urano, T., and Furukawa, K. (2000) J. Biol. Chem. 275, 5832-5837[Abstract/Free Full Text]
12. Maria, R. D., Lenti, L., Malisan, d'Agostion, F., Tomassini, B., Zeuner, A., Rippo, M. R., and Testi, R. (1997) Science 277, 1652-1655[Abstract/Free Full Text]
13. Schreck, R., and Baeuerle, P. A. (1991) Trends Cell Biol. 1, 39-42[CrossRef][Medline] [Order article via Infotrieve]
14. Sundaresan, M., Yu, Z. X., Ferrans, V., Irani, K., and Finkel, T. (1995) Science 270, 296-299[Abstract/Free Full Text]
15. Bhunia, A. K., Han, H., Snowden, A., and Chatterjee, S. (1997) J. Biol. Chem. 272, 15642-15649[Abstract/Free Full Text]
16. McCord, J. M. (1993) Clin. Biochem. 26, 351-357[CrossRef][Medline] [Order article via Infotrieve]
17. Chatterjee, S. (2000) Methods Enzymol. 311, 73-81[CrossRef][Medline] [Order article via Infotrieve]
18. Schwarzmann, G. (1978) Biochim. Biophys. Acta 529, 106-114[Medline] [Order article via Infotrieve]
19. Ross, R. (1971) J. Cell Biol. 50, 172-186[Abstract/Free Full Text]
20. Sonderfeld, S., Conzelmann, E., Schwarzmann, G., Hinrichs, U., and Sandhoff, K. (1985) Eur. J. Biochem. 149, 247-255[Medline] [Order article via Infotrieve]
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
22. Bhunia, A. K., Han, H., Snowden, A., and Chatterjee, S. (1996) J. Biol. Chem. 271, 10660-10666[Abstract/Free Full Text]
23. Selins, K. S., and Cohen, J. J. (1987) J. Immunol. 139, 3199-3206[Abstract]
24. Zhang, P., Liu, B., Kang, S. W., Seo, M. S., Rhee, S. G., and Obeid, L. M. (1997) J. Biol. Chem. 272, 30615-30618[Abstract/Free Full Text]
25. Khan, B. V., Harrison, D. G., Olbrych, M. T., Alexander, R. W., and Medford, R. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 9114-9119[Abstract/Free Full Text]
26. Hannun, Y. (1994) J. Biol. Chem. 269, 3125-3128[Free Full Text]
27. Hakomori, S. I. (1990) J. Biol. Chem. 265, 18713-18716[Abstract/Free Full Text]
28. Tillack, T. W., Allietta, M., Moren, P. E., and Young, W. W. (1993) Biochim. Biophys. Acta 793, 15-24
29. Schwarzmann, G., Hoffman-Bleihauer, P., Schubert, J., Sandhoff, K., and Marsh, D. (1983) Biochemistry 22, 5041-5048[CrossRef][Medline] [Order article via Infotrieve]
30. Zimmerman, J. W., Lindermuth, J., Fish, P. A., Palace, G. P., Stevenson, T. T., and Demong, D. E. (1998) J. Biol. Chem. 273, 22014-22020[Abstract/Free Full Text]
31. Bhunia, A. K., Arai, T., Bulkley, G., and Chatterjee, S. (1998) J. Biol. Chem. 273, 34349-34357[Abstract/Free Full Text]
32. Garcia-Ruiz, C., Colell, A., Paris, R., and Fernandez-Checa, J. C. (2000) FASEB J. 14, 847-858[Abstract/Free Full Text]
33. Garcia-Ruiz, C., Paris, R., Colell, A., and Fernandez-Checa, J. (1999) Hepatology 30, 411A (abstr.)
34. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. (1993) Cell 75, 241-251[CrossRef][Medline] [Order article via Infotrieve]
35. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., and Bredesen, D. E. (1993) Science 262, 1274-1277[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Wang, Z. Sun, A. V. Li, and K. J. Yarema
Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis: MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION, GM3 AND GD3 BIOSYNTHESIS, PROLIFERATION, AND APOPTOSIS, AND ERK1/2 PHOSPHORYLATION
J. Biol. Chem., September 15, 2006; 281(37): 27016 - 27028.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S.-K. Moon, S.-K. Kang, and C.-H. Kim
Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells
FASEB J, July 1, 2006; 20(9): 1387 - 1395.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-T. Park, M.-J. Kim, Y.-H. Kang, S.-Y. Choi, J.-H. Lee, J.-A Choi, C.-M. Kang, C.-K. Cho, S. Kang, S. Bae, et al.
Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release
Blood, February 15, 2005; 105(4): 1724 - 1733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-K. Moon, H.-M. Kim, Y.-C. Lee, and C.-H. Kim
Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression
J. Biol. Chem., August 6, 2004; 279(32): 33063 - 33070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Kim, S.-G. Sampathkumar, M. B. Jones, J. K. Rhee, G. Baskaran, S. Goon, and K. J. Yarema
Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells
J. Biol. Chem., April 30, 2004; 279(18): 18342 - 18352.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. L. Kiechle
Glycosphingolipids in Health and Disease
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. F. Wu, Y. Gu, Y. C. Xu, F. E. Nwariaku, and L. S. Terada
Vascular Endothelial Growth Factor Causes Translocation of p47phox to Membrane Ruffles through WAVE1
J. Biol. Chem., September 19, 2003; 278(38): 36830 - 36840.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Di Sano, B. Fazi, G. Citro, P. E. Lovat, G. Cesareni, and M. Piacentini
Glucosylceramide Synthase and Its Functional Interaction with RTN-1C Regulate Chemotherapeutic-induced Apoptosis in Neuroepithelioma Cells
Cancer Res., July 15, 2003; 63(14): 3860 - 3865.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Kudo, P. Rayman, C. Horton, M. K. Cathcart, R. M. Bukowski, M. Thornton, C. Tannenbaum, and J. H. Finke
Gangliosides Expressed by the Renal Cell Carcinoma Cell Line SK-RC-45 Are Involved in Tumor-induced Apoptosis of T Cells
Cancer Res., April 1, 2003; 63(7): 1676 - 1683.
[Abstract] [Full Text] [PDF]